Back
About the Global Fund
People & Structures
Back
Funding Model
Investments & Results
-
Explore contributions, investments and results in our fight against AIDS, tuberculosis and malaria around the world.
- Data Explorer
- Funding Decisions
- Data Service
HIV & AIDS
Tuberculosis
Malaria
Back
News
-
18 November 2020
Lao PDR aims to achieve universal health coverage with new Global Fund, Government of Australia and World Bank investment -
12 November 2020
Germany signs EUR150 million contribution to the Global Fund’s COVID-19 response -
12 November 2020
Global Fund Board signals strong commitment to sustain the fight against HIV, TB, malaria while supporting the global response to COVID-19 -
05 October 2020
Global Fund and Chevron: United Against HIV, TB and Malaria
Updates
-
24 November 2020
COVID-19 Situation Report -
20 November 2020
Opportunity for Evaluation of Selected Medicines -
19 November 2020
Lusophone TB Caucus launched alongside a new Lusophone Impact Report -
18 November 2020
Lao PDR aims to achieve universal health coverage with new Global Fund, Government of Australia and World Bank investment
Stories
-
25 November 2020
The hidden tragedy of COVID-19 on adolescent girls in Malawi -
19 November 2020
Why drug-resistant tuberculosis poses a major risk to global health security -
19 November 2020
COVID-19 must transform the definition of global health security -
13 November 2020
Aftab’s Story: Fighting TB in the Shadow of COVID-19 in India -
13 November 2020
Behind the COVID-19 vaccines is a hidden arsenal of diagnostic tests -
13 November 2020
In Nigeria, health workers tackle stigma and misconceptions as they fight TB and COVID-19
Back
Featured Publication
Documents by type
Information Notice
The Global Fund’s quality assurance information notices provide guidance and advice on how to operationalize in practical terms the consequences of a quality or a safety issue related to a product that has been procured with Global Fund funds. The initial information, stated in the notice, comes from the manufacturer of health products in question and/or is confirmed by stringent regulatory mechanisms.
-
Information Notices
-
QA Information Notice 2020-08 Version 2: TGF Position on the US FDA approach to mitigate shortages of rifapentine after manufacturer found nitrosamine impurities in his product.
download in English QA Information Notice 2020-08 Version 2: TGF Position on the US FDA approach to mitigate shortages of rifapentine after manufacturer found nitrosamine impurities in his product. -
QA Information Notice 2020-08: TGF Position on the US FDA approach to mitigate shortages of rifapentine after manufacturer found nitrosamine impurities in his product.
download in English QA Information Notice 2020-08: TGF Position on the US FDA approach to mitigate shortages of rifapentine after manufacturer found nitrosamine impurities in his product. -
QA Information Notice 2020-07: To remind of the importance of manufacturer’s environmental conditions during storage, transportation and distribution for Clofazimine 100mg soft capsules manufactured by Sandoz Private Limited, Kalwe MIDC, Plot No.8-A/2, 8-B T.T.C, IND. AREA Village Dighe,Navi Mumbai, 400, India
download in English QA Information Notice 2020-07: To remind of the importance of manufacturer’s environmental conditions during storage, transportation and distribution for Clofazimine 100mg soft capsules manufactured by Sandoz Private Limited, Kalwe MIDC, Plot No.8-A/2, 8-B T.T.C, IND. AREA Village Dighe,Navi Mumbai, 400, India -
QA Information Notice 2020-06: Voluntary recall of 8 Batches of Isoniazid Tablets BP 100mg, supplied by Lupin Ltd India
download in English QA Information Notice 2020-06: Voluntary recall of 8 Batches of Isoniazid Tablets BP 100mg, supplied by Lupin Ltd India -
QA Information Notice 2020-05: Voluntary recall of 20 Batches of Isoniazid Tablets BP 100mg, supplied by Lupin Ltd India.
download in English QA Information Notice 2020-05: Voluntary recall of 20 Batches of Isoniazid Tablets BP 100mg, supplied by Lupin Ltd India. -
QA Information Notice 2020-04: Falsified rapid diagnostic tests to detect HIV-1/2 circulating in Guyana and Kenya
download in English QA Information Notice 2020-04: Falsified rapid diagnostic tests to detect HIV-1/2 circulating in Guyana and Kenya -
QA Information Notice 2020-03: Temporary suspension of procurement of Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride)dispersible tablets, manufactured by SKANT LTD, India
download in English QA Information Notice 2020-03: Temporary suspension of procurement of Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride)dispersible tablets, manufactured by SKANT LTD, India -
QA Information Notice 2020-02: Recall of Batches of Sofosbuvir 400mg tablets and Temporary suspension of procurement Sofosbuvir 400mg tablets, manufactured by European Egyptian Pharmaceutical Industry, Egypt
download in English QA Information Notice 2020-02: Recall of Batches of Sofosbuvir 400mg tablets and Temporary suspension of procurement Sofosbuvir 400mg tablets, manufactured by European Egyptian Pharmaceutical Industry, Egypt -
QA Information Notice 2020-01: Serious Quality Management System issues reported on the manufacturing site of Access Bio Inc located 65 Clyde Rd. Suite A, Somerset, NJ 08873 (USA)
download in English QA Information Notice 2020-01: Serious Quality Management System issues reported on the manufacturing site of Access Bio Inc located 65 Clyde Rd. Suite A, Somerset, NJ 08873 (USA) -
QA Information Notice 2019-02b: Artesunate / Amodiaquine tablets, manufactured by Guilin Pharmaceuticals Eligibility reinstated for procurement with Global Fund (GF) funds
download in English QA Information Notice 2019-02b: Artesunate / Amodiaquine tablets, manufactured by Guilin Pharmaceuticals Eligibility reinstated for procurement with Global Fund (GF) funds -
QA Information Notice 2019-11: Suspension of the WHO Prequalification status of Tsara Soft commercialized by NRS Moon Netting
download in English QA Information Notice 2019-11: Suspension of the WHO Prequalification status of Tsara Soft commercialized by NRS Moon Netting -
QA Information Notice 2019-10: VOLUNTARY RECALL of Batch ECF7901A of Cycloserine 125 mg Capsules, supplied by Macleods and Suspension of procurement.
download in English QA Information Notice 2019-10: VOLUNTARY RECALL of Batch ECF7901A of Cycloserine 125 mg Capsules, supplied by Macleods and Suspension of procurement. -
QA Information Notice 2019-09: Urgent Field Safety Notice for products manufactured by QIAGEN, QIAsymphony SP/AS - Operating the QIAsymphony SP with software version 5.0.3
download in English QA Information Notice 2019-09: Urgent Field Safety Notice for products manufactured by QIAGEN, QIAsymphony SP/AS - Operating the QIAsymphony SP with software version 5.0.3 -
QA Information Notice 2019-08: Precautionary measures with Interceptor G2 Nets commercialized by BASF
download in English QA Information Notice 2019-08: Precautionary measures with Interceptor G2 Nets commercialized by BASF -
QA Information Notice 2019-07: Recall of Batches of Co-Trimoxazole 120mg Dispersible tablets and Temporary suspension of procurement of Co-Trimoxazole 120mg Dispersible tablets, manufactured by Chi Pharmaceuticals Limited, Nigeria
download in English QA Information Notice 2019-07: Recall of Batches of Co-Trimoxazole 120mg Dispersible tablets and Temporary suspension of procurement of Co-Trimoxazole 120mg Dispersible tablets, manufactured by Chi Pharmaceuticals Limited, Nigeria -
QA Information Notice 2019-06: Voluntary recall initiated by Macleods for ”Moxifloxacin Dispersible tablets 100mg - Batch No BMC5801A”
download in English QA Information Notice 2019-06: Voluntary recall initiated by Macleods for ”Moxifloxacin Dispersible tablets 100mg - Batch No BMC5801A” -
QA Information Notice 2019-05: Unlawfully displayed ACTm logo on boxes of Artemether + Lumefantrine 20mg + 120mg bearing various manufacturer names found in Nigeria
download in English QA Information Notice 2019-05: Unlawfully displayed ACTm logo on boxes of Artemether + Lumefantrine 20mg + 120mg bearing various manufacturer names found in Nigeria -
QA Information Notice 2019-04: Suspension of manufacturing activities at Micro Labs Limited, Kumbalgodu, ML08, Bangalore (India)
download in English QA Information Notice 2019-04: Suspension of manufacturing activities at Micro Labs Limited, Kumbalgodu, ML08, Bangalore (India) -
QA Information Notice 2019-03: The Global Fund Position on the UK MHRA Statement of non-compliance with Good Manufacturing Practices (GMP) for Micro Labs Limited, Unit 3, Hosur (India)
download in English QA Information Notice 2019-03: The Global Fund Position on the UK MHRA Statement of non-compliance with Good Manufacturing Practices (GMP) for Micro Labs Limited, Unit 3, Hosur (India) -
QA Information Notice 2019-01: Quality issues with DawaPlus 2.0 commercialized by Tana Nettings Co Ltd manufactured by H. Sheikh Noorud - Din & Sons (HSNDS) - Revised version
download in English QA Information Notice 2019-01: Quality issues with DawaPlus 2.0 commercialized by Tana Nettings Co Ltd manufactured by H. Sheikh Noorud - Din & Sons (HSNDS) - Revised version | Français psm_gfqainformationnotice2019-01-tananettings_notice_fr.pdf -
QA Information Notice 2018-07: Suspension of Dongkuk Viet Nam Co., Ltd. from the WHO/UNFPA list of prequalified male latex condom manufacturer
download in English QA Information Notice 2018-07: Suspension of Dongkuk Viet Nam Co., Ltd. from the WHO/UNFPA list of prequalified male latex condom manufacturer -
QA Information Notice 2018-06: Unlawfully displayed ACTm logo on boxes of Lesanto Laboratories
download in English QA Information Notice 2018-06: Unlawfully displayed ACTm logo on boxes of Lesanto Laboratories -
Quality Assurance Information Notice 2018-04: REMEDICA Rapid Alert Notification CY/I/07/01: Falsified Quinine Sulphate tablets 300 mg
download in English Quality Assurance Information Notice 2018-04: REMEDICA Rapid Alert Notification CY/I/07/01: Falsified Quinine Sulphate tablets 300 mg | Français psm_gfqainformationnotice2018-04_notice_fr.pdf -
Quality Assurance Information Notice 2018-01: Briefing on the Recent Changes to the Global Fund Quality Assurance Policy for Diagnostic Products with Regards to the Procurement and Testing of Malaria Rapid Diagnostic Test (RDTs)
download in English Quality Assurance Information Notice 2018-01: Briefing on the Recent Changes to the Global Fund Quality Assurance Policy for Diagnostic Products with Regards to the Procurement and Testing of Malaria Rapid Diagnostic Test (RDTs)
-
QA Information Notice 2020-08 Version 2: TGF Position on the US FDA approach to mitigate shortages of rifapentine after manufacturer found nitrosamine impurities in his product.
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.